Sign up
Pharma Capital

WideCells strengthens management and advisory team

CEO and Founder of WideCells Group (LON:WDC)  Joao Andrade tells Proactive how after recent product development/launches it's now time for the company to push through significant new appointments to make way for increased revenues during 2018.
WideCells is a worldwide healthcare services company focused on collecting and storing stem cells and providing ground breaking insurance for stem cell treatment.
Joao explains how WideCells also has plans now to look at the next stage in developing their insurance products and well as giving updates on their significant new team-up with WG Partners.


View full WDC profile View Profile

WideCells expands its reach to Spain

View All

© biotech Capital 2018

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.